Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Financing Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Financing cash flow turns negative

Q3 FY2026 financing cash flow was -$99K, compared with $29.45M a year earlier. Trailing-twelve-month financing cash flow was $28.87M. Over 3 fiscal years it compounded at -26.1% a year.

Context

  • Financing cash flow amounted to 19.2% of revenue in FY2025, down 56.7 pp from a year earlier.
  • Financing cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near -$99K or moves back toward the trailing-twelve-month quarterly average of $7.22M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$99K-100.4% QoQ
Last fiscal yearDec 2025
$40.43M-67.9% YoY
LTMSep 2026
$28.87M-73.5% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.3%——
1 year-67.9%——
3-year CAGR-26.1%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
40.43M USD
Year-over-year change
-67.9%
4-year CAGR
+77.7%

Financing Cash Flow vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 financing cash flow of $28.87M is the 2nd largest of the 4 companies compared; the peer median is $1.26M.
  • Its year-over-year change of -73.5% is the 3rd highest of 4, against a peer median of -40.4%.
  • Financing cash flow amounts to 10.9% of revenue for ESTA, versus a peer median of 17.8%.
ESTA Competitors Peer median
Financing Cash Flow for ESTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INMDInMode Ltd.LTM Mar 2026$66.66M -82.6%+45.3%17.8%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$28.87M -73.5%-26.1%10.9%
TELATELA Bio, Inc.LTM Jun 2026$25.56M -40.4%-14.3%32.0%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$1.26M +101.5%—0.1%
Peer median (excluding ESTA) $1.26M-40.4%+15.5%17.8%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
Deferred Income Tax7K86K(3.71M)(2.18M)6.96M
Stock-Based Compensation10.41M13.36M14.86M15.37M(11.42M)
Change in Working Capital(6.44M)(21.54M)(34.13M)(15.5M)(13.17M)
Accounts Receivables(6.7M)(12.33M)(11.56M)(26.28M)(11.47M)
Inventory(7.64M)(10.9M)(42.23M)(471K)(7.06M)
Accounts Payables4.96M4.38M18.96M6.67M(2.3M)
Other Working Capital2.94M(2.69M)701K4.58M7.65M
Other Non-Cash Items5.51M26.8M8.08M20.81M7.33M
Operating Cash Flow(27.53M)(52.17M)(88.51M)(58.52M)(50.89M)
Capital Expenditures(6.73M)(34.27M)(24.55M)(15.56M)(6.72M)
Acquisitions (Net)000(50K)(307K)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(434K)(525K)(16.64M)(9.45M)(672K)
Investing Cash Flow(7.16M)(34.79M)(24.55M)(15.61M)(7.03M)
Debt Repayment(175K)96.39M024.47M33.48M
Common Stock Issued4.58M3.87M84.54M99.48M7.59M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(356K)(4K)1.69M1.94M(637K)
Financing Cash Flow4.05M100.26M86.23M125.9M40.43M
Effect of Forex Changes(465K)(358K)513K(1.46M)2.71M
Net Change in Cash(31.11M)12.94M(26.32M)50.31M(14.78M)
Free Cash Flow(34.26M)(86.43M)(113.06M)(74.08M)(57.61M)

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.